ARCHIVES

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

Duke Insiders Allege Intimidation By Administration

July 23, 2010

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Avon Awards $16.2 Million To Cancer Centers, Others.

April 6, 2001

DCPC Board Ponders Screening Recommendations: Should NCI Have Policies? If So, What Will They Be?

September 26, 1986

DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening

October 20, 1989

NTP Release Third Report On Carcinogens

January 13, 1984